NASDAQ: TMCI - Treace Medical Concepts, Inc.

Yield per half year: -54.92%
Sector: Healthcare

Share chart Treace Medical Concepts, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Treace Medical Concepts, Inc., компания по производству ортопедических медицинских устройств, занимается разработкой, производством и маркетингом устройств и / или биологических решений для хирургов стопы и голеностопного сустава в США. Он предлагает процедуру лапипластики, которая позволяет хирургам-ортопедам лечить все три размера бурсита большого пальца стопы, обеспечивая пациентам косметическое и медицинское улучшение. Компания также предлагает прецизионную систему Lapiplasty Mini-Incision.

More details
Кроме того, он предлагает продукты для вспомогательных хирургических процедур, включая родственные остеотомии, остеотомию Weil, межклинную стабилизацию, слияние малых тарзометатарзальных суставов и извлечение костной ткани аутотрансплантатом, а также слияние MTP. Treace Medical Concepts, Inc. была зарегистрирована в 2014 году, ее штаб-квартира находится в Понте-Ведра-Бич, Флорида.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

P/S 9.82
P/BV 9.97
EV/EBITDA -2.69
EBITDA -0.0026
Цена ао 5.08
Число акций ао 0.06085 млрд
Сайт https://www.treace.com
Выручка 0.0394
Див.доход ао 0
ISIN US89455T1097
Валюта usd
IPO date 2021-04-23
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Change price per day: -3.42% (5.26)
Change price per week: -1.93% (5.18)
Change price per month: -0.7813% (5.12)
Change price per 3 month: -39.81% (8.44)
Change price per half year: -54.92% (11.27)
Change price per year: -51.01% (10.37)
Change price per 3 year: -70.89% (17.45)
Change price per year to date: -41.14% (8.63)
All parameters

Underestimation

Title Value Grade
P/S 4.13 4
P/BV 5.6 2
P/E 0 0
EV/EBITDA -18 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -19.66 0
ROE, % -35.91 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -1.18 10
Total: 8.6

Growth impulse

Title Value Grade
Yield Revenue, % 379.79 10
Yield Ebitda, % 1651.27 10
Yield EPS, % 639.9 10
Total: 10
More

Institutions Volume Share, %
Vanguard Group Inc 4 6.94
Blackrock Inc. 4 5.97
Morgan Stanley 3 5.31
Armistice Capital, LLC 2 3.87
William Blair Investment Management, LLC 2 3.76
Perceptive Advisors LLC 2 3.72
Millennium Management LLC 2 3.29
CIBC Private Wealth Group, LLC 2 2.99
Emerald Advisers, LLC 2 2.52
Times Square Capital Management, LLC 1 2.23

ETF Share, % Profitability for 1 year, % Dividends, %
Avantis U.S Small Cap Equity ETF 0.00057 35.517080018718 1.68271
iShares ESG Aware MSCI USA Small-Cap ETF 0.04151 39.294631710362 1.49366
Fidelity MSCI Health Care Index ETF 0.00341 16.20294599018 1.46057
Franklin U.S. Small Cap Multifactor Index ETF 0.03009 36.364464471151 1.90721
ProShares Hedge Replication ETF 0.00163 6.8665973306333 1.47892
Humankind US Stock ETF 0.00445 22.971795629061 1.99919
iShares Morningstar Small-Cap ETF 0.00524 37.681332167863 1.60498
iShares Morningstar Small-Cap Growth ETF 0.01024 41.553945249597 0.72598
iShares Russell 2000 Growth ETF 0.01957 47.42032299557 0.6026
iShares Russell 3000 ETF 0.0004 31.230028873917 1.43482
iShares Morningstar Small-Cap ETF 0.00524 410.50632631881 1.60498
iShares Morningstar Small-Cap Growth ETF 0.01024 757.51743375174 0.72598
Nuveen ESG Small-Cap ETF 0.01843 36.100211288862 1.41019
Schwab U.S. Small-Cap ETF 0.00578 -34.641922436355 1.51433
Schwab U.S. Broad Market ETF 0.00045 -56.193181818182 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00063 29.55850326668 2.19607
ProShares UltraPro Russell2000 0.00574 125.96465921385 1.47873
Vanguard Russell 3000 ETF 0 38.467141890837 1.43817
Vanguard Russell 2000 Growth ETF 0.02 46.764050831914 0.60264
Vanguard Russell 2000 ETF 0.01 32.773459189339 1.48801



Head Job title Payment Year of birth
Mr. John T. Treace CEO, Founder & Director 1.04M 1972 (52 years)
Mr. Mark L. Hair CPA Chief Financial Officer 628.6k 1970 (54 years)
Dr. Sean F. Scanlan Ph.D. Chief Innovation Officer N/A 1982 (42 years)
Mr. Daniel E. Owens Chief Human Resources Officer N/A 1972 (52 years)
Mr. Terry W. Lubben Chief Operations & Supply Chain Officer N/A 1965 (59 years)
Mr. Aaron J. Berutti Senior Vice President of Sales 519.41k 1979 (45 years)
Mr. Nathan Minnich Senior Vice President of Marketing N/A
Ms. Shana Zink Senior Vice President of Clinical Affairs & Reimbursement N/A
Mr. Taylor Erickson Chief Information Officer
Mr. Scot M. Elder J.D. Chief Legal & Compliance Officer and Corporate Secretary 1975 (49 years)

Address: United States, Ponte Vedra, FL , 203 Fort Wade Road - open in Google maps, open in Yandex maps
Website: https://www.treace.com